Structure-based design in drug discovery - the application of a peptoid drug design strategy for the development of non-peptide neuropeptide receptor ligands

By Pritchard M.C.   Raphy J.   Singh L.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 4, 1997-04 ,pp. : 349-365

Informa Healthcare

Access to resources Recommend Favorite

Understanding Functional Residues of the Cannabinoid CB1 Receptor for Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 8, 2010-06 ,pp. : 779-798

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of Selective Ligands for the Cannabinoid CB2 Receptor

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 3, 2008-01 ,pp. : 187-204

Bentham Science Publishers

Access to resources Recommend Favorite

CB1 Cannabinoid Receptor Ligands

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 7, 2005-07 ,pp. : 631-640

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Cannabinoid CB2 Receptor: Mutations, Modeling and Development of CB2 Selective Ligands

By  

Current Medicinal Chemistry, Vol. 12, Iss. 10, 2005-05 ,pp. : 1217-1237

Bentham Science Publishers

Access to resources Recommend Favorite